BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 2468873)

  • 1. Regression of myocardial and coronary vascular hypertrophy in hypertensive heart disease.
    Strauer BE
    J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S45-54. PubMed ID: 2468873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of sympathetic nervous activity on regression of cardiac hypertrophy.
    Strauer BE; Bayer F; Brecht HM; Motz W
    J Hypertens Suppl; 1985 Dec; 3(4):S39-44. PubMed ID: 2937889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of hypertensive cardiac hypertrophy and impaired coronary microcirculation.
    Motz W; Strauer BE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S34-8. PubMed ID: 7533225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of cardiac failure by coronary small vessel disease in hypertensive heart disease?
    Strauer BE
    J Hypertens Suppl; 1991 Dec; 9(2):S11-20; discussion S20-1. PubMed ID: 1838764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of cardiac hypertrophy: experimental and clinical results.
    Motz W; Klepzig M; Strauer BE
    J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S148-52. PubMed ID: 2485021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary hemodynamics in hypertensive heart disease. Basic concepts, clinical consequences, and experimental analysis of regression of hypertensive microangiopathy.
    Strauer BE
    Am J Med; 1988 Mar; 84(3A):45-54. PubMed ID: 2975465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional dynamics of the left ventricle in hypertensive hypertrophy and failure.
    Strauer BE
    Hypertension; 1984; 6(6 Pt 2):III4-12. PubMed ID: 6240452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical repair of hypertensive left ventricular remodeling.
    Motz WH; Scheler S; Strauer BE
    J Cardiovasc Pharmacol; 1992; 20 Suppl 1():S32-6. PubMed ID: 1380616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progression and regression of heart hypertrophy in arterial hypertension: pathophysiology and clinical aspects].
    Strauer BE
    Z Kardiol; 1985; 74 Suppl 7():171-8. PubMed ID: 2936017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The coronary circulation in hypertensive heart disease.
    Strauer BE
    Hypertension; 1984; 6(6 Pt 2):III74-80. PubMed ID: 6240456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular dynamics, energetics and coronary hemodynamics in hypertrophic heart disease.
    Strauer BE
    Eur Heart J; 1983 Jan; 4 Suppl A():137-42. PubMed ID: 6220892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of left ventricular hypertrophy and improvement of cardiac function in man by nifedipine.
    Strauer BE; Atef Mahmoud M; Bayer F; Bohn I; Motz U
    Eur Heart J; 1984 Dec; 5 Suppl F():53-60. PubMed ID: 6241903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary reserve in experimental myocardial hypertrophy.
    Gosse P; Clementy J
    Eur Heart J; 1995 Aug; 16 Suppl I():22-5. PubMed ID: 8829953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of coronary circulation in hypertensive heart disease for development and prevention of heart failure.
    Strauer BE
    Am J Cardiol; 1990 Apr; 65(14):34G-41G. PubMed ID: 2138855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of cardiac hypertrophy after therapy in animal hypertension.
    Motz W; Strauer BE
    J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S56-61. PubMed ID: 2409372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings].
    Klaus D
    Z Kardiol; 1985; 74 Suppl 7():153-69. PubMed ID: 2936016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasodilators and regression of left ventricular hypertrophy. Hydralazine versus prazosin in hypertensive humans.
    Leenen FH; Smith DL; Farkas RM; Reeves RA; Marquez-Julio A
    Am J Med; 1987 May; 82(5):969-78. PubMed ID: 2953239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk reduction following regression of cardiac hypertrophy.
    Schmieder RE
    Clin Exp Hypertens A; 1990; 12(5):903-16. PubMed ID: 2145097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hypertensive heart disease with ACE inhibitors.
    Stumpe KO
    J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S166-71. PubMed ID: 2485024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.